Abstract | BACKGROUND: OBJECTIVE: This study was performed in order to determine whether IL-6 could be detected specifically in collagen-stimulated peripheral blood mononuclear cells from patients with systemic sclerosis. METHODS: We clinically evaluated seven patients with systemic sclerosis for disease duration and organ involvement and analyzed in vitro the ability of their peripheral blood mononuclear cells and those of disease-free controls, in the presence of concanavalin A, human type I collagen, and the mast cell mediator, heparin to secrete IL-6 spontaneously by a sensitive ELISA. RESULTS:
Interleukin-6 production by nonspecific stimulation with concanavalin A did not differ between patients with systemic sclerosis and controls; however, collagen stimulation significantly increased IL-6 production in patients with systemic sclerosis; mean 1728 pg/mL versus a mean of 386 pg/mL in controls P = < .05). Collagen-stimulated IL-6 levels > 2000 pg/mL were obtained in 86% of patients with systemic sclerosis compared with none in the controls. In patients with systemic sclerosis with a shorter disease duration, greater spontaneous as well as collagen- and heparin-stimulated IL-6 production was observed, whereas decreased IL-6 levels were noted with longer disease duration (> 21 years). CONCLUSIONS: The results of this study suggest that peripheral blood mononuclear cells from patients with systemic sclerosis are specifically sensitized to human type I collagen to produce increased levels of IL-6, which may play a role in the pathogenesis in this fibrotic disorder.
|
Authors | M Gurram, S Pahwa, M Frieri |
Journal | Annals of allergy
(Ann Allergy)
Vol. 73
Issue 6
Pg. 493-6
(Dec 1994)
ISSN: 0003-4738 [Print] United States |
PMID | 7998663
(Publication Type: Clinical Trial, Journal Article)
|
Chemical References |
- Interleukin-6
- Concanavalin A
- Collagen
|
Topics |
- Adult
- Aged
- Cells, Cultured
- Collagen
(pharmacology)
- Concanavalin A
(pharmacology)
- Female
- Humans
- Interleukin-6
(metabolism)
- Leukocytes, Mononuclear
(drug effects)
- Male
- Middle Aged
- Scleroderma, Systemic
(blood, metabolism)
|